Combination therapy of interleukin-2 (il-2) analog or conjugate thereof and CTLA-4 antagonist for preventing or treating cancer

TW202639155APending Publication Date: 2026-10-01HANMI PHARM CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114142430
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-10-31
Filing Date
2025-10-31
Publication Date
2026-10-01

Smart Images

  • Figure 00000000_0000_ABST
    Figure 00000000_0000_ABST
Patent Text Reader

Abstract

The present invention relates to the combined use of an interleukin-2 analog or a conjugate thereof and a CTLA-4 antagonist for preventing or treating cancer; and a pharmaceutical composition comprising the same.
Need to check novelty before this filing date? Find Prior Art